ChemMedChem · 2008 · 13 citations · 13 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryNeuropharmacologyStructure-activity RelationshipsLigand BindingLigand-based DesignReceptor PharmacologySerotonergic PharmacologySerotonergic Signaling5-Hydroxytryptamine 1A Receptor Agonists5-Hydroxytryptamine Receptor PharmacologyAgonist ActivitySerotonergic AgonistsSerotonergic Drug DiscoverySerotonin AgonistsSerotonin Receptor PharmacologySerotonin Receptor Subtypes
Abstract A selective 5‐HT 1A receptor agonist : A new series of ligands acting at 5‐HT 1A serotonin receptor were identified. Among them (2,2‐diphenyl‐[1,3]oxathiolan‐5‐yl‐methyl)‐(3‐phenyl‐propyl)amine (shown) possesses outstanding activity (p K i =8.72, pD 2 =7.67, E max =85) and selectivity (5‐HT 1A /α 1D >150), and represents a new 5‐HT 1A agonist chemotype. magnified image Starting from compound 1 , a previously reported α 1D ‐adrenoceptors antagonist, a new series of ligands acting at 5‐HT 1A serotonin receptor were identified through simple structure modifications. Among them (2,2‐diphenyl‐[1,3]oxathiolan‐5‐yl‐methyl)‐(3‐phenyl‐propyl)amine ( 19 ) exhibits outstanding activity (p K i =8.72, pD 2 =7.67, E max =85) and selectivity (5‐HT 1A /α 1D >150), and represents an as yet unidentified 5‐HT 1A agonist scaffold.
13
Lee E. Schechter, Daniel L. Smith, Sharon Rosenzweig‐Lipson et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 130 citations · Full text
Medicine, Neuroscience, Pharmacology +17